Well the good news is that there aren't all that many shares to begin with. Because of this, I've always seen massive potential here, if we can get this to market either in China (regulated) or anywhere else (unregulated, wearable/wellness), even without ever getting FDA approval. Of course, I'm disappointed in the way things have gone recently with the upcoming dilution and delay, but if you take a couple steps back, there is still massive potential. Even if they dilute now by 100% (doubtful) and this company's market cap ever returns to the $200+ million, this will represent huge gains from here. But $200 million market cap is peanuts compared with what it will be if approved in China alone, let alone the wellness market and potential FDA approval. So my personal, non-professional opinion is load up here while you can and don't worry about dilution at this point.
Good luck
News 
Market Data 
Discover 
